232 related articles for article (PubMed ID: 26691175)
1. Adjuvant radiation therapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials- an update.
Budach W; Bölke E; Kammers K; Gerber PA; Nestle-Krämling C; Matuschek C
Radiat Oncol; 2015 Dec; 10():258. PubMed ID: 26691175
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant radiotherapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials.
Budach W; Kammers K; Boelke E; Matuschek C
Radiat Oncol; 2013 Nov; 8():267. PubMed ID: 24225206
[TBL] [Abstract][Full Text] [Related]
3. Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial.
Poortmans PM; Weltens C; Fortpied C; Kirkove C; Peignaux-Casasnovas K; Budach V; van der Leij F; Vonk E; Weidner N; Rivera S; van Tienhoven G; Fourquet A; Noel G; Valli M; Guckenberger M; Koiter E; Racadot S; Abdah-Bortnyak R; Van Limbergen EF; Engelen A; De Brouwer P; Struikmans H; Bartelink H;
Lancet Oncol; 2020 Dec; 21(12):1602-1610. PubMed ID: 33152277
[TBL] [Abstract][Full Text] [Related]
4. Which target volume should be considered when irradiating the regional nodes in breast cancer? Results of a network-meta-analysis.
Haussmann J; Budach W; Tamaskovics B; Bölke E; Corradini S; Djiepmo-Njanang FJ; Kammers K; Matuschek C
Radiat Oncol; 2019 Jun; 14(1):102. PubMed ID: 31186015
[TBL] [Abstract][Full Text] [Related]
5. Does the intent to irradiate the internal mammary nodes impact survival in women with breast cancer? A population-based analysis in British Columbia.
Olson RA; Woods R; Speers C; Lau J; Lo A; Truong PT; Tyldesley S; Olivotto IA; Weir L
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e35-41. PubMed ID: 22342092
[TBL] [Abstract][Full Text] [Related]
6. Internal mammary nodal irradiation in conservatively-managed breast cancer patients: is there a benefit?
Obedian E; Haffty BG
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):997-1003. PubMed ID: 10421532
[TBL] [Abstract][Full Text] [Related]
7. [Controversy about internal mammary chain irradiation in breast cancer].
Hennequin C; Fourquet A
Cancer Radiother; 2014 Oct; 18(5-6):351-5. PubMed ID: 25169067
[TBL] [Abstract][Full Text] [Related]
8. [Evidence-based radiotherapy in the treatment of operable breast cancer: results in the 1990-ies].
Fodor J; Polgár C; Németh G
Orv Hetil; 2000 Jul; 141(28):1551-5. PubMed ID: 10957865
[TBL] [Abstract][Full Text] [Related]
9. Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissection.
Setton J; Cody H; Tan L; Morrow M; Hudis C; Catalano J; McCormick B; Powell S; Ho A
Cancer; 2012 Apr; 118(8):1994-2003. PubMed ID: 21882186
[TBL] [Abstract][Full Text] [Related]
10. Can the addition of regional radiotherapy counterbalance important risk factors in breast cancer patients with extracapsular invasion of axillary lymph node metastases?
Gruber G; Berclaz G; Altermatt HJ; Greiner RH
Strahlenther Onkol; 2003 Oct; 179(10):661-6. PubMed ID: 14566473
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival outcomes following internal mammary node irradiation in stage II-III breast cancer: results of a large retrospective study with 12-year follow-up.
Chang JS; Park W; Kim YB; Lee IJ; Keum KC; Lee CG; Choi DH; Suh CO; Huh SJ
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):867-72. PubMed ID: 23747215
[TBL] [Abstract][Full Text] [Related]
12. Postmastectomy radiotherapy in intermediate risk stage I-II breast cancer patients.
Mladenovic J; Susnjar S; Gavrilovic D; Borojevic N
J BUON; 2007; 12(2):215-20. PubMed ID: 17600875
[TBL] [Abstract][Full Text] [Related]
13. Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group.
Benchalal M; Le Prisé E; de Lafontan B; Berton-Rigaud D; Belkacemi Y; Romestaing P; Peignaux K; Courdi A; Monnier A; Montcuquet P; Goudier MJ; Marchal C; Chollet P; Abadie-Lacourtoisie S; Datchary J; Veyret C; Kerbrat P
Cancer; 2005 Jul; 104(2):240-50. PubMed ID: 15948160
[TBL] [Abstract][Full Text] [Related]
14. Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer.
Poortmans PM; Collette S; Kirkove C; Van Limbergen E; Budach V; Struikmans H; Collette L; Fourquet A; Maingon P; Valli M; De Winter K; Marnitz S; Barillot I; Scandolaro L; Vonk E; Rodenhuis C; Marsiglia H; Weidner N; van Tienhoven G; Glanzmann C; Kuten A; Arriagada R; Bartelink H; Van den Bogaert W;
N Engl J Med; 2015 Jul; 373(4):317-27. PubMed ID: 26200978
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Adjuvant Radiation Therapy Alone Versus Radiation Therapy and Endocrine Therapy in Elderly Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Treated With Breast-Conserving Surgery.
Murphy CT; Li T; Wang LS; Obeid EI; Bleicher RJ; Eastwick G; Johnson ME; Hayes SB; Weiss SE; Anderson PR
Clin Breast Cancer; 2015 Oct; 15(5):381-9. PubMed ID: 25861716
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for regional nodal relapse in breast cancer patients with one to three positive axillary nodes.
Yates L; Kirby A; Crichton S; Gillett C; Cane P; Fentiman I; Sawyer E
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2093-103. PubMed ID: 21530101
[TBL] [Abstract][Full Text] [Related]
17. The association of internal mammary and medial supraclavicular lymph node radiation technique with clinical outcomes: Results from the EORTC 22922/10925 randomised trial.
Kaidar-Person O; Fortpied C; Hol S; Weltens C; Kirkove C; Budach V; Peignaux-Casasnovas K; van der Leij F; Vonk E; Valli M; Weidner N; Guckenberger M; Koiter E; Fourquet A; Bartelink H; Struikmans H; Poortmans P;
Radiother Oncol; 2022 Jul; 172():99-110. PubMed ID: 35568284
[TBL] [Abstract][Full Text] [Related]
18. Postoperative loco-regional radiation therapy for breast cancer patients with four or more involved lymph nodes or extracapsular extension.
Evron E; Barzily L; Rakowsky E; Ben-Baruch N; Sulkes J; Rizel S; Fenig E
Isr Med Assoc J; 2005 Jul; 7(7):439-42. PubMed ID: 16011059
[TBL] [Abstract][Full Text] [Related]
19. Internal Mammary Node Radiation in Light of the EORTC 22922 and MA.20 Trials-What Have We Really Learned?
Verma V; Beriwal S
JAMA Oncol; 2016 Aug; 2(8):992-3. PubMed ID: 27244127
[No Abstract] [Full Text] [Related]
20. Irradiation of regional lymph node areas in breast cancer - Dose evaluation according to the Z0011, AMAROS, EORTC 10981-22023 and MA-20 field design.
Borm KJ; Oechsner M; Düsberg M; Buschner G; Weber W; Combs SE; Duma MN
Radiother Oncol; 2020 Jan; 142():195-201. PubMed ID: 31540747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
